Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
iScience
2021 Nov 19;2411:103282. doi: 10.1016/j.isci.2021.103282.
Show Gene links
Show Anatomy links
DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease.
Joshi BS
,
Youssef SA
,
Bron R
,
de Bruin A
,
Kampinga HH
,
Zuhorn IS
.
???displayArticle.abstract??? Huntington disease (HD) is a devastating neurodegenerative disorder characterized by aggregation of huntingtin (HTT) protein containing expanded polyglutamine (polyQ) tracts. DNAJB6, a member of the DNAJ chaperone family, was reported to efficiently inhibit polyQ aggregation in vitro, in cell models, and in vivo in flies, xenopus, and mice. For the delivery of exogenous DNAJB6 to the brain, the DNAJB6 needs to be protected against (enzymatic) degradation and show good penetration into braintissue. Here, we tested the potential of small extracellular vesicles (sEVs) derived from neural stem cells (NSCs) for delivery of DNAJB6 as anti-amyloidogenic cargo. Administration of sEVs isolated from DNAJB6-overexpressing cells to cells expressing expanded polyQ tracts suppressed HTT aggregation. Furthermore, intrathecal injection of DNAJB6-enriched sEVs into R6/2 transgenic HD mice significantly reduced mutant HTT aggregation in the brain. Taken together, our data suggest that sEV-mediated molecular chaperone delivery may hold potential to delay disease onset in HD.
Alpaugh,
Disease-modifying effects of ganglioside GM1 in Huntington's disease models.
2017, Pubmed
Alpaugh,
Disease-modifying effects of ganglioside GM1 in Huntington's disease models.
2017,
Pubmed
Balch,
Adapting proteostasis for disease intervention.
2008,
Pubmed
Balchin,
In vivo aspects of protein folding and quality control.
2016,
Pubmed
Bason,
Astrocytic expression of the chaperone DNAJB6 results in non-cell autonomous protection in Huntington's disease.
2019,
Pubmed
Bobrie,
Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation.
2012,
Pubmed
Chai,
Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.
1999,
Pubmed
Davies,
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
1997,
Pubmed
Dedeoglu,
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice.
2003,
Pubmed
Ferrante,
Mouse models of Huntington's disease and methodological considerations for therapeutic trials.
2009,
Pubmed
Ha,
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges.
2016,
Pubmed
Hageman,
A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.
2010,
Pubmed
,
Xenbase
Hoshino,
Tumour exosome integrins determine organotropic metastasis.
2015,
Pubmed
Howarth,
Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease.
2007,
Pubmed
Jahn,
The Yin and Yang of protein folding.
2005,
Pubmed
Kakkar,
The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse Model.
2016,
Pubmed
Kuiper,
Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch.
2017,
Pubmed
Labbadia,
Suppression of protein aggregation by chaperone modification of high molecular weight complexes.
2012,
Pubmed
Lee,
Exosome-Based Delivery of miR-124 in a Huntington's Disease Model.
2017,
Pubmed
Lee,
Cellular Engineering with Membrane Fusogenic Liposomes to Produce Functionalized Extracellular Vesicles.
2016,
Pubmed
Mangiarini,
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
1996,
Pubmed
Månsson,
Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation.
2018,
Pubmed
Månsson,
Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Aβ42) aggregates leads to sub-stoichiometric inhibition of amyloid formation.
2014,
Pubmed
Mathieu,
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication.
2019,
Pubmed
Meng,
Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.
2016,
Pubmed
Müller-Taubenberger,
Monomeric red fluorescent protein variants used for imaging studies in different species.
2006,
Pubmed
Nakase,
Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes.
2015,
Pubmed
Narain,
A molecular investigation of true dominance in Huntington's disease.
1999,
Pubmed
NULL,
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
1993,
Pubmed
Orr,
Trinucleotide repeat disorders.
2007,
Pubmed
Ramirez,
Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.
2018,
Pubmed
Ross,
Huntington's disease: from molecular pathogenesis to clinical treatment.
2011,
Pubmed
Sato,
Engineering hybrid exosomes by membrane fusion with liposomes.
2016,
Pubmed
Schneider,
Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders.
2013,
Pubmed
Shen,
Protein targeting to exosomes/microvesicles by plasma membrane anchors.
2011,
Pubmed
Skotland,
Lipids in exosomes: Current knowledge and the way forward.
2017,
Pubmed
Sterzenbach,
Engineered Exosomes as Vehicles for Biologically Active Proteins.
2017,
Pubmed
Takeuchi,
Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases.
2017,
Pubmed
Takeuchi,
Intercellular chaperone transmission via exosomes contributes to maintenance of protein homeostasis at the organismal level.
2015,
Pubmed
Théry,
Exosomes: composition, biogenesis and function.
2002,
Pubmed
Thiruvalluvan,
DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis.
2020,
Pubmed
Tkach,
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go.
2016,
Pubmed
Valenza,
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice.
2015,
Pubmed
Wanker,
Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.
1999,
Pubmed
Warrick,
Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.
1999,
Pubmed
Wiklander,
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting.
2015,
Pubmed
Yang,
The cis-acting signals that target proteins to exosomes and microvesicles.
2013,
Pubmed
Zomer,
In Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior.
2015,
Pubmed
